Related Experiment Videos
[Malignancy potential of precursor lesions: determination using molecular markers].
1Pathologisches Institut, Ludwig-Maximilians-Universität, Thalkirchner Str. 36, 80337, München, Deutschland. Andreas.Jung@med.uni-muenchen.de
Der Pathologe
|September 21, 2011
Summary
Early detection of cancer relies on prognostic biomarkers. Identifying human papillomavirus (HPV) and p16(INK4a) expression aids in assessing cervical cancer precursor lesions and progression risk.
Area of Science:
- Oncology
- Molecular Biology
- Pathology
Background:
- Early cancer detection significantly improves patient prognosis and curative treatment outcomes.
- Prognostic biomarkers are crucial for assessing the risk of progression in precursor lesions.
- Current knowledge of prognostic biomarkers for early-stage and later neoplastic diseases remains limited.
Purpose of the Study:
- To highlight the necessity of prognostic biomarkers for risk stratification in oncologic diseases.
- To discuss known biomarkers like human papillomavirus (HPV) infection and p16(INK4a) expression in cervical cancer.
- To explore the potential of biomarker signatures for defining precursor lesions in complex tumor pathogenesis.
Main Methods:
- Review of established biomarkers for early cancer detection, specifically HPV and p16(INK4a) in cervical carcinomas.
- Discussion of oncogen-induced senescence (OIS) as an indicator of premalignant epithelial cell states.
- Exploration of tumor pathogenesis complexity and the role of functionally different subtypes in biomarker discovery.
Main Results:
- Human papillomaviruses (HPV) are identified as oncogenic drivers in most cervical carcinomas.
- p16(INK4a) expression serves as an indicator of oncogen-induced senescence (OIS) and a premalignant state.
- The complexity of solid tumor pathogenesis necessitates the identification of biomarker signatures for precursor lesions.
Conclusions:
- Effective early cancer detection and risk assessment depend on the availability of reliable prognostic biomarkers.
- HPV and p16(INK4a) are key indicators in cervical cancer precursor lesion detection.
- Understanding tumor heterogeneity is vital for developing biomarker signatures to define and manage neoplastic precursor lesions.
Related Concept Videos
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...